Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management

NCT ID: NCT03015363

Last Updated: 2021-08-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-30

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the Cloud DX Pulsewave Health Monitor study is to prospectively calibrate and validate a novel, non-invasive wrist cuff blood pressure device against the gold standard for hemodynamic monitoring (intra-arterial pressure) in voluntarily consented patient participants who are scheduled for an elective cardiac catheterization procedure for clinically valid reasons.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Cloud DX Pulsewave Health Monitor is a non-invasive wrist cuff blood pressure device that is licensed by Health Canada with Food and Drug Administration approval. Systolic and diastolic pressures are measured via the arterial pulse waveform of the left radial artery. Initially, the blood pressure algorithm was created and calibrated using the auscultatory method. The purpose of this study is to calibrate the device to the clinical gold standard of peripheral and central intra-arterial pressures.

The device acquires a pulse signal in real-time, stores signal and measurement data, and displays stored signal and measurement data for interpretation via internet servers where it is accessible by end-users (physicians and/or patients). The system provides secure accounts for both in-patient and out-patient monitoring. Cloud DX's Pulsewave Health Monitor servers are housed in a secure data center. Privacy measures are to SSAE16 SOC-1 Type-II compliance: 1) restricted secure access, 2) dedicated firewall, 3) HTTPS channel communication via website, 4) self-encrypting hard-drives rendered useless if removed from the server.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 19 years of age
* Patients recommended by their cardiologist for a first-time, elective cardiac catheterization procedure
* Wrist circumference between 13.5cm - 23cm (5.3 - 9.1in.)
* Bilateral arm blood pressure equality (systolic within ±10mmHg; diastolic within ±5mmHg) on 2 separate readings (Nurse Associate \& TRA)
* Willing to volunteer to participate and to sign the study specific informed consent form

Exclusion Criteria

* No history of peripheral vascular disease, no previous percutaneous coronary intervention, nor previous coronary artery bypass graft
* No arrhythmia
* No abdominal aortic aneurysm
* No hand/body tremor
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Horizon Health Network

OTHER

Sponsor Role collaborator

Dalhousie University

OTHER

Sponsor Role collaborator

Cloud DX Inc.

INDUSTRY

Sponsor Role collaborator

New Brunswick Health Research Foundation

OTHER

Sponsor Role collaborator

Cardiovascular Research New Brunswick

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sohrab Lutchmedial, MD, FRCPC

Co-Director of CVR-NB/ Director of NBHC Catheterization Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sohrab Lutchmedial, MD, FRCPC

Role: PRINCIPAL_INVESTIGATOR

Cardiovascular Research New Brunswick

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Horizon Health Network

Saint John, New Brunswick, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Melville S, Teskey R, Philip S, Simpson JA, Lutchmedial S, Brunt KR. A Comparison and Calibration of a Wrist-Worn Blood Pressure Monitor for Patient Management: Assessing the Reliability of Innovative Blood Pressure Devices. J Med Internet Res. 2018 Apr 25;20(4):e111. doi: 10.2196/jmir.8009.

Reference Type DERIVED
PMID: 29695375 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.clouddx.com/

Device company website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RS#: 2013-1919

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vital Signs Blood Pressure Trial
NCT06272318 NOT_YET_RECRUITING
Contactless Radar Blood Pressure Validation
NCT06035107 NOT_YET_RECRUITING